The EMHA worked along KPMG on a market research to understand the patient journey and burden of disease for migraine in 12 countries. The Access to care survey 2021 has shown insightful results on the patients’ access to treatment and care in each of their country. Summary of the “Access To Care III” survey results … Continue reading Access to care survey 2021